Evidence map›Paper›PMID 32535667›Full record

ArticleGlycoconjugate journal2020

Click chemistry compared to thiol chemistry for the synthesis of site-selective glycoconjugate vaccines using CRM

G Stefanetti, M Allan, A Usera, F Micoli

Open access · hybridAbstract read
In one paragraph

Article in Glycoconjugate journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

G StefanettiDepartment of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA, 02115, USA. giuseppe_stefanetti@hms.harvard.edu.ORCID 0000-0002-2796-4817
M AllanNovartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, MA, 02139, USA.
A UseraNovartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, MA, 02139, USA.
F MicoliGSK Vaccines Institute For Global Health (GVGH) S.r.l, Via Fiorentina 1, Siena, 53100, Italy.
Harvard University · USToscana Life Sciences · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Conjugation chemistry is one of the main parameters affecting immunogenicity of glycoconjugate vaccines and a rational approach toward a deeper understanding of their mechanism of action will greatly benefit from highly-defined and well-characterized structures. Herein, different conjugation methods were investigated with the aim of controlling glycosylation site and glycosylation density on the carrier protein. S. Typhimurium lipopolysaccharide O-Antigen and CRM

Indexed as

Bacterial ProteinsCarrier ProteinsClick ChemistryGlycoconjugatesHumansLipopolysaccharidesO AntigensSalmonella InfectionsSalmonella typhimuriumSulfhydryl CompoundsVaccinesBacterial ProteinsCarrier ProteinsCRM197 (non-toxic variant of diphtheria toxin)GlycoconjugatesLipopolysaccharidesO AntigensSulfhydryl CompoundsVaccinesClick chemistryConjugation chemistryCRM197Glycoconjugate vaccineO-antigenSalmonella TyphimuriumThiol chemistry

Identifiers

PMID32535667
PMCPMC7501094
OpenAlexW3035300607

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.